Gangliosides, highly expressed in the outer leaflet of plasma membranes, mediate a variety of biological processes, including cell-cell and cell-matrix interactions. We examined the effects of exogenous gangliosides on intracellular Ca 2+ mobilization and functional responses in human platelets. Gangliosides (GM 3 and GM,) induced rapid and reversible elevation of intracellular Ca 2+ in fura2-loaded platelets in a concentration-dependent manner. The Ca 2+ -mobilizing effect of gangliosides was not mimicked by de-N-acetyl-GMj, lactosylceramide, or free sialic acid, suggesting that structural integrity as ganglioside is essential for this effect. GM, and GM, also induced platelet shape change by themselves and elicited aggregation in combination with epinephrine. Our observations suggest the involvement of ganglioside-activated platelets in atherosclerosis, in view of the high observed ganglioside levels in atherosclerotic lesions of human aorta.
Introduction
Circulating blood platelets are very sensitive to various stimuli and react within s of exposure. The process of platelet activation must be highly regulated; normallyfunctioning platelets play a central role in hemostatic reactions, whereas overactive platelets are implicated in the pathogenesis of harmful processes such as thrombosis and atherosclerosis. These processes constitute an integrated group of multicellular or cell-matrix events involving platelet interactions with endothelial cells, erythrocytes, neutrophils, and subendothelium (Marcus, 1994) .
Gangliosides (sialic acid-containing glycosphingolipids) and their modified catabolites are highly expressed in the outer leaflet of plasma membranes and mediate a variety of biological processes (Hakomori, 1990; Hakomori and Igarashi, 1993; Nagai, 1995) . One important function appears to be mediation of cell-cell and cell-matrix (environment) interactions (Hakomori, 1990; Hakomori and Igarashi, 1993; Nagai, 1995) . Since such interactions are an essential part of platelet-dependent phenomena, elucidation of ganglioside involvement in platelet activation is of importance. We investigated the short-term effects of gangliosides GM 3 and GMi and their derivatives on intracellular Ca 2+ mobilization and functional responses in human platelets.
Results

Ganglioside-induced intracellular Ca
2 * mobilization in platelets When [Ca 2+ ], was measured in human platelets loaded with the Ca 2+ -sensitive fluorophore fura2, GM 3 induced a rapid and transient increase in [Ca 2+ ],. The peak value occurred within 20 s of addition, and was followed by a low plateau phase, which remained slightly elevated as compared with baseline value ( Figure 1A ). When platelets were challenged with ionomycin, a Ca 2+ ionophore, a similar initial surge was observed, but this was followed by a high sustained response, as compared with GM 3 -induced Ca 2+ signal ( Figure IB) . GM 3 -induced intracellular Ca 2+ mobilization was concentration-dependent from 1 /i.M to 100 /MM ( Figure 2A ) and mimicked by gangliosides GM] ( Figure  2B ) and GM 2 (data not shown). De-N-acetyl-gangliosides, in which the N-acetyl group of sialic acid is eliminated and the free amino group of the resulting neuraminic acid residue is exposed, is present physiologically in various types of cells (Hanai et al, 1988; Zhou et al, 1994; Sjoberg etal., 1995) . We found that de-N-acetyl-GM 3 , in contrast to parent GM 3 , did not induce intracellular Ca 2+ mobilization ( Figure 2B ). Lactosylceramide (in which the sialic acid moiety of GM 3 is lost), gangliotriaosylceramide (asialo-GM 2 ), and free sialic acid also failed to elicit platelet [Ca 2+ ], increase ( Figure 2B ).
The effects of various agents known to interact with platelet signaling pathways on GM 3 -induced intracellular Ca 2+ mobilization were examined. Chelation of extracellular Ca 2+ by addition of 1 mM EGTA (instead of Ca 2+ ) resulted in only a slight reduction of [Ca 2+ ], increase ( Figure  3 ). This indicates that GM 3 stimulates Ca 2+ mobilization mainly from intracellular stores. Prostaglandin Ei activates adenylate cyclase through mediation by its receptor and stimulatory GTP-binding protein, and hence inhibits platelet activation at several steps (Siess, 1989) . Incubation of platelets with prostaglandin E, blocked GM 3 -induced [Ca 2+ ]i increase (Figure 3 ). In contrast, epinephrine, which potentiates platelet activation (Siess, 1989; Siess, 1991; Lanza et al, 1988) , significantly enhanced the process (Figure 3) . Cytochalasin B, which inhibits actin polymerization and related platelet functional responses (Fox and Phillips, 1981; Nakano et al, 1989) , had no effect on the [Ca 2+ ], increase induced by GM 3 (Figure 3 ) or by thrombin (data not shown), a platelet agonist which acts on its G proteincoupled receptor (Siess, 1989; Vu et al, 1991) . Under the same conditions, cytochalasin B completely abolished collagen-induced [Ca 2+ ], increase (data not shown), which is consistent with the established concept that collagen-in- 25 100 GM, , . 100 jig/ ml of lactosylceramide (LacCer) or gangliotriaosylceramide (Gg3), or 100 jtM sialic acid (SA). Results are mean ± SD (n = 3). duced phospholipase C activation and resultant Ca 2+ mobilization in platelets are dependent on reorganization of the cytoskeleton (Nakano et al, 1989) .
Platelet functional responses elicited by gangliosides Intracellular Ca
2+ mobilization plays a key role in platelet activation (Siess, 1989) . Since gangliosides are platelet Ca 2+ mobilizers, we expected them to elicit platelet functional responses. We first measured platelet shape change. Decrease in light transmission of a stirred platelet suspension reflected a change from discoid to spheroid shape (Zucker, 1989) . Administration of GM 3 resulted in rapid shape change ( Figure 4A ) which was comparable to the response induced by collagen (data not shown), a potent and physiological platelet agonist (Siess, 1989) . This effect of GM 3 was dose-dependent ( Figure 5A ) and was mimicked by ], increase. Platelets were preincubated with 1 mM EGTA (instead of CaCl : ) for 1 mm, 5 fiM prostaglandin E, (PGE,) for 5 min, 1 /nM epinephrine (Epi) for 1 min, or 10 ^tg/ml cytochalasin B (CB) for 5 min, and then stimulated with 100 fiM GMj. Data are expressed as percentages of control values obtained from GM 3 -stimulated platelets without pretreatment, mean ± SD (n = 3).
GM, ( Figure 5B ). As in the case of intracellular Ca 2+ mobilization ( Figure 2B ), neither de-N-acetyl-GM 3 nor lactosylceramide elicited platelet shape change ( Figure 5B ). The Ca 2+ ionophore ionomycin induced shape change (Figure 5B) ; this process is dependent on Ca 2+ signaling (Siess, 1989) .
When added alone, GM 3 ( Figure 4B ) or GM, (data not shown) induced minimal aggregation. Synergistic interaction of platelet agonists provides an efficient amplification mechanism for platelet activation. This is particularly true when platelets are challenged with epinephrine, which is classified as a weak platelet stimulator (Siess, 1989; Siess, 1991; Lanza etai, 1988) . We therefore examined synergism between ganglioside and epinephrine in induction of platelet aggregation. Epinephrine by itself, at concentrations below 10 (J.M, did not induce platelet aggregation ( Figure  4C ), in agreement with previous reports (Lanza et ai, 1988) . When platelets were preincubated with epinephrine and then challenged with GM 3 , strong aggregation was observed ( Figure 4E ). When GM 3 was added first, followed by epinephrine, there was no aggregation ( Figure 4D ). The aggregation-inducing effect of GM 3 (in combination with epinephrine) was concentration-dependent ( Figure 6A ) and mimicked by GM b but not by de-N-acetyl-GM 3 or lactosylceramide ( Figure 6B ). Subthreshold concentrations of ionomycin and epinephrine synergistically elicited aggregation ( Figure 6B ), as described previously (Siess, 1991) . In another experiment, epinephrine and GM 3 were added at various time intervals, and synergistic effects in platelet aggregation were examined. Strong aggregation was observed only when epinephrine and GM 3 were added simultaneously or the former addition was followed by the latter (Figure 7 ). When GM 3 was added before epinephrine addition, the synergistic effect was greatly reduced. In con- trast, synergism between epinephrine and ionomycin was observed regardless of addition intervals (Figure 7) .
We also performed platelet 5-hydroxytryptamine release studies, but neither GM 3 nor GM!, at concentrations less than 100 /xM, elicited release (data not shown).
Discussion
Platelet activation plays an important role in the physiological regulation of hemostasis, and also in pathological processes such as thrombosis and atherosclerosis. Intracellular Ca 2+ is an important mediator of this activation (Siess, 1989) . Our data corroborate the findings of Vasylevskaya etai (Vasylevskaya etai, 1992) , who first reported ganglioside-induced platelet intracellular Ca 2+ mobilization and suggested that, in a number of characteristics, the action of gangliosides parallels that of platelet soluble agonists; i.e. we observed that (i) the action of gangliosides is rapid and reversible; (ii) gangliosides stimulate Ca 2+ mobilization mainly from internal stores; (iii) the Ca 2+ -mobilizing effects of gangliosides, as well as those of soluble platelet agonists, are potentiated by epinephrine and inhibited by prostaglandin Ei. The Ca 2+ signal induced by gangliosides (and soluble agonists) can be clearly distinguished from that produced by collagen, a thrombogenic macromolecule in- teracting with platelets mainly via integrin a^i (Staatz et al, 1989) ; i.e. collagen-induced Ca 2+ mobilization is sensitive to cytochalasin B (Nakano et al, 1989) . We observed that GM 3 , GM], and GM 2 induce intracellular Ca 2+ mobilization, while Vasylevskaya et al. observed that GD 3 and GM 3 elicit this signaling event (Vasylevskaya et al, 1992) . In human keratinocytes, GQ lb , GTi b , and GM! induce Ca 2+ mobilization (Seishima etai, 1993) . Presumably, the ability of gangliosides to induce intracellular Ca 2+ mobilization is generalized rather than limited to a particular species of ganglioside. However, the finding that the Ca 2+ -mobilizing effect of GM 3 is not mimicked by de-N-acetyl-GM 3 , lactosylceramide, or free sialic acid ( Figure 2B ) suggests that structural integrity as ganglioside (sialic acid-containing oligosaccharide conjugated to hydrophobic ceramide molecule) is essential for this effect. We previously reported that de-N-acetyl-GM 3 stimulates EGF receptor kinase activity and cell proliferation, in contrast to the inhibitory effects of parent GM 3 (Hanai etal, 1988; Zhou et al, 1994) . Whereas GM 3 elicits intracellular Ca 2+ mobilization, de-N-acetyl-GM 3 does not (present study). De-N-acetyl-gangliosides are considered physiological compounds and have been detected in various cell types (Hanai et aL, 1988; Zhou et al, 1994; Sjoberg et al, 1995) . Conversion between ganglioside and its de-N-acetyl derivative may provide opposing modulators of intracellular signaling.
Effects of exogenous ganglioside on cell physiological processes are often studied as a means of clarifying ganglio- side function. The effect of ganglioside on cell growth and transmembrane signaling through growth factor receptors occurs slowly, and is based on insertion of ganglioside into plasma membrane, followed by interaction with receptor (Hakomori, 1990; Hakomori and Igarashi, 1993) . For example, Yates et al. previously reported that the treatment of Swiss 3T3 cells with various gangliosides long term (2 days) inhibits PDGF-induced receptor-coupled intracellular Ca 2+ mobilization (Yates et al., 1993) . In contrast, ganglioside has much more rapid effect on Na + /K + ATPase, Ca 2+ ATPase, and Ca 2+ channel involved in neurotansmission. These processes are associated with synaptosomal membranes, and have been discussed extensively (Thomas and Brewer, 1990; Rahmann, 1989; Rahmann et aL, 1988) . Ganglioside-induced Ca 2+ mobilization as described in this paper is also rapid response. The process is similar to those observed for Ca 2+ mobilization agonists such as thrombin, which induce receptor-mediated phospholipase C activation rather than non-specific perturbation of plasma membrane or ionophore-like effect, Ganglioside-induced phosphoinositide hydrolysis (phospholipase C activation), resulting in Ca 2+ mobilization, has been reported in keratinocytes (Seishima et aL, 1993) . Nevertheless, the mechanism that induces Ca 2+ mobilization in platelets is yet unknown.
How can exogenous ganglioside trigger specific signaling pathways? One possibility is that ganglioside may interact with ganglioside present at the platelet surface (i.e. GM3, the major ganglioside of platelets), resulting in reorganization of clustered gangliosides, which induces activation of key enzymes involved in signaling, e.g. phospholipase C. There is abundant biochemical and biophysical evidence of ganglioside-ganglioside interaction (Kojima and Hakomori, 1989; Kojima and Hakomori, 1991; Brewer and Matinyan, 1992) .
A second possibility is that ganglioside may bind specifically to gangliophilic protein at the plasma membrane, to directly affect function of the protein, e.g. activation of key enzymes for triggering of transmembrane signaling. Presence of endogenous proteins which preferentially bind to specific gangliosides has been reported (Watanabe et aL, 1980; Tiemeyer et aL, 1990; Hattori et aL, 1995) .
It was reported that both GM 3 and GM b when immobilized on plastic, fail to stimulate adherence of platelets (Mazurov et aL, 1988) . On the contrary, we observed that free GM 3 (but not de-N-acetyl-GM 3 or lactosylceramide) and GM] which were added into the medium induce platelet shape change by themselves and synergistically elicit aggregation in combination with epinephrine. These results suggest that not only the sialic acid-containing sugar structure but also the hydrophobic ceramide moiety might be involved in the stimulation, although the reasons underlying the difference between our observation with free gangUosides and the previous one with immobilized gangliosides is not completely clear at present. The concentration-dependency of shape change and aggregation induction (in combination with epinephrine) by GM 3 correlated closely with the concentration required for Ca 2+ release (Figures 2A, 5A , and 6A). These functional responses induced by gangliosides were all mimicked by the Ca 2+ -ionophore ionomycin under the same conditions ( Figures 5B and 6B) . Therefore, intracellular Ca 2+ mobilization is probably important in gangliosideinduced platelet activation, although we cannot rule out the possibility that other intracellular pathway(s) are activated by ganglioside. Previous reports have suggested a synergism between Ca 2+ ionophore and epinephrine in induction of platelet aggregation, although the underlying mechanism(s) are not well denned (Siess, 1989; Siess, 1991) . This synergism is observable regardless of the intervals between Ca 2+ ionophore (ionomycin) and epinephrine additions (Figure 7 ). In contrast, in the synergism between the ganglioside GM 3 and epinephrine, challenge with epinephrine must come prior to or simultaneously with GM 3 stimulation (Figure 7 ). This can be attributed to the fact that ganglioside-induced Ca 2+ signal is transient and rapidly returns to near basal level after addition, whereas ionomycin-elicited Ca 2+ signal is longlasting (Figure 1 ). We suggest that epinephrine has no effect after Ca 2+ signal subsides, and that Ca 2+ increase plays an essential role in ganglioside-induced platelet aggregation (in combination with epinephrine). To support this, vasopressin, which transiently induces intracellular Ca 2+ mobilization (Siess, 1989) , also acts similarly to gangliosides in synergism with epinephrine to induce platelet aggregation (data not shown).
Ganglioside levels in atherosclerotic lesions of human aorta are considerably higher than those in normal aorta, and involvement of aortic gangliosides in development of atherosclerosis has been suggested (Prokazova and Bergelson, 1994) . Our data support this idea, and suggest that conditions which elevate blood levels of catecholamines also promote ganglioside-elicited activation of platelets.
Platelet activation is believed to play a role in the cancer metastatic process, and circulating tumor gangliosides have been reported to enhance platelet activation (Valentino and Ladisch, 1994) . Thus, roles of ganglioside-induced platelet activation in various pathological processes are an important subject for future study.
Materials and methods
Materials GM) was prepared from dog erythrocytes and purified by DEAE-Sephadex, followed by HPLC on an Iatrobeads 6RS8010 column (Iatron Laboratories, Tokyo, Japan). De-N-acetyl-GM 3 was prepared by mild alkaline hydrolysis of GM, (with 0.1 N KOH in 90% 1-butanol) and separated by HPLC(Norese(a/., 1988). Lactosylceramide (from dog erythrocytes) and gangliotriaosylceramide (from guinea pig erythrocytes) were prepared as described (Hakomori, 1983) .
The following materials were obtained from the indicated suppliers: ionomycin (Calbiochem, La Jolla, CA); fura2/AM (Molecular Probes, Eugene, OR), GM,, cytochalasin B, and fibnnogen (Sigma, St. Louis, MO); prostaglandin E, (Biomol, Plymouth Meeting, PA); epinephnne (Chrono-Log, Havertown, PA); 5-[2-14C]hydroxytryptamine (56.4 mCi/ mmol) (Du Pont-New England Nuclear, Boston, MA).
Platelet preparation
Washed platelets were prepared as described (Yatomi et al., 1994) , and resuspended in a buffer solution of 138 mM NaCI, 3.3 mM NaH 2 PO 4 , 2.9 mM KC1, 1.0 mM MgCl 2 , 1 mg/ml of glucose, and 20 mM HEPES (pH 7.4). Suspensions were adjusted to 3 X lOVml and supplemented with 1 mM CaCl 2 unless stated otherwise. For shape change studies, platelets were left for at least 60 min at 37°C after final centrifugation because this resulted in greater response. All experiments using intact platelet suspensions were performed at 37°C. -sensitive fluorophore fura2 as described previously (Yatomi et al., 1992) , except that fluorescence measurements were made using a Perkin-Elmer LS50B (Norwalk, CT).
Measurement of intracellular
Platelet aggregation and shape change
These processes were determined in a Platelet Ionized Calcium Aggregometer (Chrono-Log, Havertown, PA), with stirring at 1000 r.p.m.. The instrument was calibrated with platelet suspension for zero light transmission and buffer for 100% transmission. Shape change was observed by adding 5 mM EDTA (instead of CaCl 2 ) before administration of stimuli to prevent aggregation, and indicated by a decrease in light transmission (Zucker, 1989) . For measurement of aggregation, human fibnnogen (500 /ig/ml) was added to platelet suspensions shortly before stimulation. The increase in light transmission caused by platelet aggregation (Zucker, 1989) was continuously recorded.
For quantitative evaluation of both processes (when indicated), results were expressed as the maximum change of light transmission within 3 min after stimulation.
Platelet 5-hydroxytryptamine release
Release reaction from platelets labeled with [ M C]5-hydroxytryptamine was analyzed as described (Yatomi et al., 1992) 
